The trademark application EASi-KIDNEY was filed by Boehringer Ingelheim International GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on August 17, 2023, and it was registered by office on November 24, 2023 without any oppositions.
The application was filed in German (English was selected as the second language).